All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a non-profit multi-stakeholder collaborative program that aims to unify, accelerate and build on existing efforts to make precision medicine a reality for all patients who could benefit from it. Co-led by patients, FT3 is strongly focused on patient needs and experiences.

All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a collaborative program to make precision medicine a reality for all patients who could benefit from it.

All patients deserve access to the right testing & treatment at the right time

Participate now in a public consultation for the co-created Precision Medicine Patient Stories Library

Discover the Story of Precision Medicine

A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories.

Program highlights

The Story of Precision Medicine

A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories..

 

Program update – November 2022

Here is an overview of upcoming opportunities to contribute, as well as some recent news and updates from FT3.

Empowering patients with advanced or metastatic colorectal cancer – “This Q&A adaptable resource really helps”

About us

Our motivation

All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.

Our ambition

Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.

The partnership

We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.

Keep up to date with developments from the precision medicine ecosystem

We don’t spam. Just key info at the right time.